May 15, 2024 / 08:30PM GMT
Operator
Good afternoon, everyone, and welcome to the Panbela Therapeutics first-quarter 2024 earnings call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, James Carbonara, Investor Relations. James, over to you.
James Carbonara - HaydenIR - Investor Relations
Thank you, operator. Joining me on today's call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer .
Before we begin, please note that statements made on this call that are not historical facts may be considered forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements are detailed in the company's filings with the SEC.
Any forward-looking statements made on this call speak only as of today's date. And the company does not undertake any obligation to update or revise any of these statements to reflect future events or circumstances.
With that, I will turn
Q1 2024 Panbela Therapeutics Inc Earnings Call Transcript
May 16, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers